Skip to content

Comprehensive cancer testing to turn uncertainty into clarity

Get the information you need for better cancer treatment options.

Order now

patient

CancerVision

CancerVision is a whole genome test that unveils a comprehensive picture of your genome and helps you explore the answers you need.

See your cancer from new angles for more answers

More than a quarter of cancer patients1 have complicated genetic mutations that are often missed by other tests. CancerVision uses whole genome testing designed to help uncover critical information that other tests could have missed.

In addition to your test, you’ll also receive services that will equip you with the resources you need to make sense of your test results.

 

Whole genome coverage

Standard panel genetic testing for cancer looks at less than 0.1% of your genome2, leaving lots of room for unanswered questions. CancerVision provides an extensive analysis of your genomic makeup to give you and your healthcare provider more detailed information about your cancer.

Easy-to-understand reports

After testing, you’ll receive a report that is detailed and easy to understand. It provides insights about your cancer and known mutations to help you and your healthcare provider make informed decisions tailored to your unique body, empowering you on your healthcare journey.

Support from genetic counselors

When you order CancerVision, you get automatic access to a genetic counselor to guide you through your results. We’ll make sure you understand the findings and potential treatment options.

Clinical trial matching support

Only 8%3 of eligible cancer patients are enrolled in clinical trials in the US. We identify clinical trial matches based on your biomarkers and additional criteria and can connect you with enrollment support services upon your request.

How to order a test

If you need support, email us at inquiry@inocras.com. We can help facilitate the process by working with you.

Sign up

Fill out the order request form and consent form at our patient portal.

Clinical request

An external clinician will review and approve your test request.

Blood sample collection

Once your test request is approved, we’ll send you a link to make an appointment for a phlebotomist to visit your home and draw your blood for a blood test.

Tumor tissue sample collection

We will need a tissue sample to run the test. Based on the information you provide, we will work with your care team/pathologist’s office to collect it. No action is required from you.

genetic-counselor-appointment

Genetic counselor appointment

When your report is ready, you will get a notification with a link to make an appointment with a genetic counselor.

Result review

A genetic counselor will review your CancerVision report and clinical trial matching report with you.

Lung cancer diagnosis informs a successful treatment regimen

Steven, 70, had a cancerous mass removed from his small intestine but lacked answers about where his primary tumor was located. CancerVision was ordered to help clarify the origin of the primary cancer and to confirm a diagnosis. The test discovered a tobacco-related molecular signature that led to a diagnosis of metastatic non-small cell lung cancer. This known gene mutation was used to develop a medical care plan and treatment strategies for Steven that led to consistent progress.

dr with patient

Breast cancer patient finds improved health with clinical trial

Sarah, 52, was diagnosed with stage IV breast cancer and wasn’t responding to immunotherapy or chemo treatments. Her provider ordered a CancerVision test, which pinpointed a genetic structural change in Sarah’s RAD51C gene. This mutated gene wasn’t found by other types of genetic tests. This finding led to the decision to enroll her in a clinical trial for a new drug, which has since improved her health.

40 yr old woman

Shedding light on cancer’s hereditary nature

Emily, 40, was diagnosed with breast cancer after receiving a sarcoma diagnosis at a young age. Her oncologist ordered CancerVision, which uncovered a genetic mutation in her TP53 gene. This finding led to a diagnosis of Li-Fraumeni syndrome, which is associated with a high cancer risk. This gene mutation was not detected in other panel tests, yet it provided Emily’s physician with a better understanding of the nature of her hereditary cancer. This led to testing her sibling to get a better understanding of how cancer may affect her other family members and whether they were at increased risk of developing cancer.

40yr old woman

**While all patient names provided are fictionalized to ensure privacy and confidentiality, the age, disease information, and diagnostic process in the testimonials are based on real cases. Please note that clinical outcomes may vary for each individual.

Your questions – answered

If you don’t see your question answered here, please contact us at inquiry@inocras.com.

How can I order a test?

CancerVision tests can be ordered online using our secure portal. Once you fill out the order form, a telehealth provider will review your test order request and the test will be ordered after they review your order and information. Click here to be directed to the order form.

Is the test covered by health insurance?

Currently, our whole genome sequencing medical tests are not yet covered by health insurance in the US. We are working on insurance coverage to provide easy access to all patients.

Outside of the US, our products may be covered by insurance, but it varies significantly by the country and types of insurance. We suggest reaching out to your insurer to confirm. If you need any support exploring it, please contact us at inquiry@inocras.com.

Is CancerVision expensive?

We understand that cost is an important consideration for patients, and we believe that access to whole genome testing should not be solely limited by cost. We strive to offer this valuable testing at an average comparable price so that it’s accessible to as many people as possible.

It’s important to note that the cost of genomic testing can vary depending on several factors, such as the specific test and additional services included. We recommend reaching out to our team at inquiry@inocras.com to discuss specific pricing details and any available financial assistance programs.

What kind of samples are collected, and who collects them?

For CancerVision, we will need a tissue sample and a blood sample. We will work with your pathologist’s office to collect tissue samples. In the order request form, you will need to provide your pathologist office information or your treating oncologist information. With your consent, we can also pull the information from your medical records. Your pathologist will get detailed sample collection requirements and instructions.

To collect your blood sample, we provide an at-home blood-draw service, where a phlebotomist will come to your home and collect your blood at your convenience.

How will my test results be shared with me?

Once your test is done, your results will be shared with a genetic counselor, who will then share the genetic test results with you directly. We will send you an email for you to make an appointment with a genetic counselor and discuss your results.

What if I have questions about my results?

Our team of in-house experts will explain the results to your provider and offer recommendations for how to use them. As a patient, you’ll also receive genetic counseling to walk through the results and make sure you understand your test findings and your options – at no additional cost.